Group One Trading
ELEV

Group One Trading’s Elevation Oncology ELEV Stock Holding History

Group One Trading’s Portfolio ELEV Stock Details ELEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-118
Closed -$43 – 8572
2025
Q2 		$43 Buy
118
+18
+18% +$6 ﹤0.01% 7809
2025
Q1 		$26 Hold
100
– – ﹤0.01% 7439
2024
Q4 		$56 Hold
100
– – ﹤0.01% 7121
2024
Q3 		$60 Buy
+100
New +$148 ﹤0.01% 6494

Other funds holding ELEV

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Group One Trading's ELEV Position: Q3 2025 in Review

Group One Trading sold out of Elevation Oncology (ELEV) in Q3 2025, closing a stake of 118 shares — an estimated $43 sold.

Group One Trading first reported a position in ELEV in Q3 2024 and held it in 4 quarters. The position peaked at $60 in Q3 2024. 1 fund tracked by Wall St. Rank holds ELEV as of Q3 2025.

  • Group One Trading reported no remaining Elevation Oncology position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 118 Elevation Oncology shares in Q3 2025, an estimated $43.
  • Group One Trading first reported a position in Elevation Oncology in Q3 2024 and held it in 4 quarters.
  • Group One Trading's Elevation Oncology position peaked at $60 in Q3 2024.
  • 1 fund tracked by Wall St. Rank held Elevation Oncology as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.